Actylis – The Partner of Choice

Activities: Manufacturing Ingredients Research & Development

Trending Articles

  1. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA...
  2. Buckland Group launches Quvara Medical after acquiring Becton Dickinson’s Swindon site to boost UK-EU medical manufacturing The acquisition establishes Quvara Medical as a new UK- and EU-based CMO offering GMP- and ISO-certified, high-volume manufacturing services to pharma and medtech clients
  3. Domino’s Adem Kulauzovic appointed to the Board of OMAC Domino’s Adem Kulauzovic appointed to the Board of OMAC to help shape the future of packaging automation
  4. Manufacturing Chemist Stand Side with Almac Group We discover what exhibitors at CPHI 2025 are showcasing LIVE!
  5. Ardena strengthens leadership team with new quality and information officers Appointments reinforce focus on quality, compliance, and digital integration across global operations

Upcoming event

Pharmapack

21–22 January 2026 | Exhibition | Paris, France See all

Related Content

Manufacturing

Actylis expands into VMS & Pharma with the acquisition of Pharm-Rx

The acquisition strengthens Actylis’ presence in the VMS and OTC markets
Manufacturing

Actylis appoints Scott Thomson as CEO

Scott will endeavour to globally expand the company's integrated manufacturing and sourcing strategy
Distribution

Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride

The two companies aim to expand the distribution of benzalkonium chloride within Europe
Manufacturing

Actylis adds a WFI production system in Canada

The manufacturer of raw materials has launched a Water for Injection (WFI) and additional ISO Class 7 manufacturing in Montreal, Canada
Manufacturing

Actylis opens 30,000 sqft cGMP API facility

The Eugene facility is the latest GMP manufacturing facility that Actylis has commissioned, along with the other GMP sites in Montreal, Limerick and Ahmedabad
Manufacturing

Actylis invests $450k in Manchester facility, UK

The modernisation work was completed during the summer of 2022
Manufacturing

The debut of Actylis signals the creation of a specialty ingredients manufacturing and sourcing powerhouse

The unique hybrid model provides unparalleled flexibility for individualised, customer-centric ingredient solutions along with exceptional supply chain dependability
Subscribe now